Company / Accounts Receivable
iBio, Inc. Accounts Receivable History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.0M
FY2024
5-year range
$426.0K / $1.0M
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 9 years, ranging from $75,000 in FY2020 to $1M in FY2024.
Based on SEC 10-K filings.
$1M in FY2024 with a 5-year CAGR of +59.5%.
Improved from $426,000 to $1M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +32.9%
- 5-Year CAGR
- +59.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +59.5%, indicating consistent growth.
- In FY2024, accounts receivable increased 0.0% year-over-year.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.0M | +0.0% |
| FY2023 | $1.0M | +134.7% |
| FY2022 | $426.0K | +0.0% |
| FY2021 | $426.0K | +468.0% |
| FY2020 | $75.0K | -22.7% |
| FY2019 | $97.0K | +29.3% |
| FY2018 | $75.0K | -57.1% |
| FY2017 | $175.0K | -63.8% |
| FY2016 | $484.0K | +8.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026